bio-america-crispr-2018-scientifictracks

15 / 20

Page 44
Notes:
&
24th Biotechnology Congress: Research & Innovations
CRISPR Cas9 Technology and Genetic Engineering
Annual Congress on
October 24-25, 2018 | Boston, USA
Journal of Biotechnology & Biomaterials | ISSN: 2155-952X | Volume: 8
Analytical next-generation sequencing approaches for CRISPR-Cas9-mediated cell engineering
Haythem Latif
GENEWIZ, USA
C RISPR-Cas9-mediated cell lines hold great promise to transform therapeutics in various disease areas. Next-generation
sequencing (NGS) is a powerful analytical tool with applications designed throughout the CRISPR-Cas9 workflow from
discovery, through screening, and to validation of CRISPR-Cas9 effects. Here we will review contemporary workflows for
CRISPR-Cas9 knockout libraries and briefly highlight how NGS and advanced informatics facilitates drug target identification.
We will also detail various routes for optimizing and screening CRISPR-Cas9 pools and isolates for on- and off-target activity.
Moving beyond screening and lead identification, we will review novel unguided NGS approaches to demonstrate on-target
specificity while confirming low/no off-target activity prior to clinical trials.
Biography
Haythem Latif is a life science professional with a passion for next-generation sequencing technologies and applications. His interests in NGS began during his
time as a graduate student pursing a PhD in Bioengineering from the University of California, San Diego. There, he generated, analyzed, and integrated multi-omic
datasets to deeply characterize the genome organization of various microbial organisms in search of novel biological insights. Upon graduation, he worked for
ThermoFisher in the Ion Torrent applications team focusing on AmpliSeq panel development. He is currently managing NGS Business & Strategic Partnerships at
GENEWIZ.
Haythem Latif, J Biotechnol Biomater 2018, Volume 8
DOI: 10.4172/2155-952X-C4-097